This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
The Marsha Rivkin Center for Ovarian Cancer Research
Canary Foundation
Swedish Medical Center
City of Hope Medical Center
Cedars-Sinai Medical Center
Stanford University
Fox Chase Cancer Center
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01121640
First received: May 10, 2010
Last updated: September 19, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)